Hepion Pharmaceuticals Inc share price logo

Hepion Pharmaceuticals Inc Share Price

NASDAQ: HEPA

$0.07

-0.07

(-49.76%)

as on

Bell Icon

The stock has been delisted from the stock exchange on 12 May 2025

Hepion Pharmaceuticals Inc Stock Performance

as on September 9, 2025 at 7:01 pm IST

  • Day's Low

    Day's High

    $0.32
    $0.32
    downward going graph

    -357.14%

    Downside

    357.14%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.25
    $44.5
    downward going graph

    -257.14%

    Downside

    63471.43%

    Upside

    downward going graph

Hepion Pharmaceuticals Inc share price movements today

Previous Close
$0.14
Open
$0.32
Volume
2.1K
Day's Low - High
$0.32 - $0.32
52 Week Low - High
$0.25 - $44.5

Hepion Pharmaceuticals Inc Historical Returns

1 Month Return
0 %
3 Month Return
0 %
1 Year Return
0 %
3 Year Return
0 %
5 Year Return
0 %

Hepion Pharmaceuticals Inc Stock Fundamentals & Key Indicators

Check Hepion Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$-

EPS (TTM)

0

Dividend Yield

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

Return On Equity TTM

0.00%

Hepion Pharmaceuticals Inc stock Key Stats

Compare market cap, revenue, PE, and other key metrics of Hepion Pharmaceuticals Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
BUY$-NANA0.00%

Analyst Recommendation on Hepion Pharmaceuticals Inc Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Hepion Pharmaceuticals Inc. Average target price of $30

Hepion Pharmaceuticals Inc Share Price Target

Get share price movements and forecasts by analysts on Hepion Pharmaceuticals Inc.

What analysts predicted

99.77%UPSIDE

Target Price

$30

Current Price

$0.07

Analyzed by

8 Analysts

Target

$30.00

Hepion Pharmaceuticals Inc target price $30, a slight upside of 99.77% compared to current price of $0.07. According to 8 analysts rating.

Hepion Pharmaceuticals Inc Quarterly Profit & Loss

All numbers in Millions USD

Dec 2022
Mar 2023
Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Total Revenue
-
-
-
-
-
0
-
-
-
Gross Profit
-
0
0
0
-
0
-
-
-
Operating Income
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-6
-13
-14
-10
-11
-2
-3
-4
-1
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
-2600.75%
0.00%
0.00%
0.00%

Hepion Pharmaceuticals Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2015
Dec 2016
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
Operating Income
-
-
-
-
-
-
-
-
-
EBITDA
-
-
-
-
-
-
-
-
-
Interest Expense
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
Income Before Tax
-
-
-
-
-
-
-
-
-
Income Tax Expense
-
-
-
-
-
-
-
-
-
Net Income
-14
-16
-9
-7
-20
-32
-42
-48
-13
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Global Institutional Holdings in Hepion Pharmaceuticals Inc

Funds
Holdings
Anson Funds Management LP
0.43%
BlackRock Inc
0.15%
Vanguard Group Inc
0.09%
Geode Capital Management, LLC
0.08%
Susquehanna International Group, LLP
0.05%

About Hepion Pharmaceuticals Inc

Hepion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on artificial intelligence (AI)-driven therapeutic drug development for the treatment of non-alcoholic steatohepatitis (NASH), fibrotic diseases, hepatocellular carcinoma (HCC), and other chronic diseases. Its primary asset, Rencofilstat, is a potent inhibitor of cyclophilins, which are involved in many disease processes. Rencofilstat reduces liver fibrosis and hepatocellular carcinoma tumor burden in experimental disease models. Its drug candidate is intended to target multiple molecular pathways across the full spectrum of liver disease progression, from the triggering events that initiate disease to the pathological events that directly impair liver function and integrity. Its AI-POWR platform provides integrative, multi-variate, systems-biology bioinformatic and big-data analysis of proprietary pre-clinical and clinical data with publicly available multi-omic databases.
OrganisationHepion Pharmaceuticals Inc
E-voting on sharesClick here to vote

FAQs

What is Hepion Pharmaceuticals Inc share price today?

Hepion Pharmaceuticals Inc share price today is $0.07 as on at the close of the market. Hepion Pharmaceuticals Inc share today touched a day high of $0.32 and a low of $0.32.

What is the 52 week high and 52 week low for Hepion Pharmaceuticals Inc share?

Hepion Pharmaceuticals Inc share touched a 52 week high of $44.5 on and a 52 week low of $0.25 on . Hepion Pharmaceuticals Inc stock price today i.e. is closed at $0.07,which is 99.84% down from its 52 week high and -72.00% up from its 52 week low.

How to invest in Hepion Pharmaceuticals Inc Stock (HEPA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Hepion Pharmaceuticals Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Hepion Pharmaceuticals Inc Shares that will get you 21.4286 shares as per Hepion Pharmaceuticals Inc share price of $0.07 per share as on September 9, 2025 at 7:01 pm IST.

What is the minimum amount required to buy Hepion Pharmaceuticals Inc Stock (HEPA) from India?

Indian investors can start investing in Hepion Pharmaceuticals Inc (HEPA) shares with as little as ₹88.455 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹884.55 in Hepion Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Hepion Pharmaceuticals Inc share’s latest price of $0.07 as on September 9, 2025 at 7:01 pm IST, you will get 142.8571 shares of Hepion Pharmaceuticals Inc. Learn more about fractional shares .